546
Views
2
CrossRef citations to date
0
Altmetric
Invited Review

Pediatric Scleritis: An Update

, MDORCID Icon, , MDORCID Icon, , MD, , MD, PhDORCID Icon, , MD, PhD, , MDORCID Icon, , MD, PhDORCID Icon & , MD, PhDORCID Icon show all
Pages 175-184 | Received 17 Aug 2021, Accepted 07 Nov 2021, Published online: 28 Feb 2022

References

  • Homayounfar G, Nardone N, Borkar DS, et al. Incidence of scleritis and episcleritis: results from the Pacific Ocular Inflammation Study. Am J Ophthalmol. 2013 Oct;156(4):752–758. doi:10.1016/j.ajo.2013.05.026. Epub 2013 Jul 24. PMID: 23891336; PMCID: PMC3852161.
  • Honik G, Wong IG, Gritz DC. Incidence and prevalence of episcleritis and scleritis in Northern California. Cornea. 2013 Dec;32(12):1562–1566. doi:10.1097/ICO.0b013e3182a407c3. PMID: 24145628.
  • Sainz de La Maza M, Molina N, Gonzalez-Gonzalez LA, et al. Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Ophthalmology. 2012 Jan;119(1):43–50. doi:10.1016/j.ophtha.2011.07.013. Epub Oct 2, 2011. Epub Oct 2, 2011. PMID: 21963265.
  • Lin P, Bhullar SS, Tessler HH, et al. Immunologic markers as potential predictors of systemic autoimmune disease in patients with idiopathic scleritis. Am J Ophthalmol. 2008 Mar;145(3):463–471. doi:10.1016/j.ajo.2007.09.024. Epub Dec 3, 2007. Erratum in: Am J Ophthalmol. 2008 Jun;145(6):1111. PMID: 18061135.
  • Sainz de La Maza M, Foster CS, Jabbur NS. Scleritis associated with systemic vasculitic diseases. Ophthalmology. 1995 Apr;102(4):687–692. doi:10.1016/s0161-6420(95)30970-0. PMID: 7724185.
  • Sainz de La Maza M, Jabbur NS, Foster CS. Severity of scleritis and episcleritis. Ophthalmology. 1994 Feb;101(2):389–396. doi:10.1016/s0161-6420(94)31325-x. PMID: 8115160.
  • Sims J. Scleritis: presentations, disease associations and management. Postgrad Med J. 2012 Dec;88(1046):713–718. doi:10.1136/postgradmedj-2011-130282. Epub Sep 12, 2012. PMID: 22977282.
  • Majumder PD, Ali S, George A, et al. Clinical profile of scleritis in children. Ocul Immunol Inflamm. 2019;27(4):535–539. doi:10.1080/09273948.2017.1423333. Epub Jan 25, 2018. PMID: 29370565.
  • Abd El Latif E, Seleet MM, and El Hennawi H, et al. Pattern of scleritis in an Egyptian cohort. Ocul Immunol Inflamm. 2019;27(6):890–896. doi:10.1080/09273948.2018.1544372. Epub Nov 9, 2018. PMID: 30412434.
  • Ahn SJ, Oh JY, Kim MK, et al. Clinical features, predisposing factors, and treatment outcomes of scleritis in the Korean population. Korean J Ophthalmol. 2010 Dec;24(6):331–335. doi:10.3341/kjo.2010.24.6.331. Epub Nov 23, 2010. PMID: 21165230; PMCID: PMC2992559.
  • Akpek EK, Thorne JE, Qazi FA, et al. Evaluation of patients with scleritis for systemic disease. Ophthalmology. 2004 Mar;111(3):501–506. doi:10.1016/j.ophtha.2003.06.006. PMID: 15019326.
  • Al Barqi M, Behrens A, Alfawaz AM. Clinical features and visual outcomes of scleritis patients presented to tertiary care eye centers in Saudi Arabia. Int J Ophthalmol. 2015 Dec 18;8(6):1215–1219. doi:10.3980/j.issn.2222-3959.2015.06.25. PMID: 26682176; PMCID: PMC4651892.
  • Jabs DA, Mudun A, Dunn JP, et al. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol. 2000 Oct; 130(4):469–476. doi:10.1016/s0002-9394(00)00710-8. PMID: 11024419.
  • Keino H, Watanabe T, Taki W, et al. Clinical features and visual outcomes of Japanese patients with scleritis. Br J Ophthalmol. 2010 Nov;94(11):1459–1463. doi:10.1136/bjo.2009.171744. Epub Jun 24, 2010.
  • Lane J, Nyugen E, Morrison J, et al. Clinical features of scleritis across the Asia-Pacific region. Ocul Immunol Inflamm. 2019;27(6):920–926. doi:10.1080/09273948.2018.1484496. PMID: 29953309.
  • Manandhar A. Patterns of uveitis and scleritis in Nepal: a tertiary referral center study. Ocul Immunol Inflamm. 2017;25(sup1):S54–S62. doi:10.3109/09273948.2016.1161804. Epub May 18, 2016. PMID: 27191731.
  • Rahman Z, Jafarullah O, Huq N, et al. Clinical profile of patients with scleritis in Bangladesh. Ocul Immunol Inflamm. Mar 4 2020:1–4. doi:10.1080/09273948.2020.1716026. Epub ahead of print. PMID: 32130057.
  • Tanaka R, Kaburaki T, Ohtomo K, et al. Clinical characteristics and ocular complications of patients with scleritis in Japanese. Jpn J Ophthalmol. 2018 Jul;62(4):517–524. doi:10.1007/s10384-018-0600-y. Epub May 23, 2018. PMID: 29796754.
  • Yang P, Ye Z, Tang J, et al. Clinical features and complications of scleritis in Chinese patients. Ocul Immunol Inflamm. 2018;26(3):387–396. doi:10.1080/09273948.2016.1241282. Epub Nov 16, 2016. PMID: 27849414.
  • Zhang Y, Amin S, Lung KI, Seabury S, Rao N, Toy BC. Incidence, prevalence, and risk factors of infectious uveitis and scleritis in the United States: a claims-based analysis. PLoS One. 2020;15(8):e0237995. doi:10.1371/journal.pone.0237995.
  • Beardsley RM, Suhler EB, Rosenbaum JT, et al. Pharmacotherapy of scleritis: current paradigms and future directions. Expert Opin Pharmacother. 2013 Mar;14(4):411–424. doi:10.1517/14656566.2013.772982. Epub Feb 21, 2013. PMID: 23425055; PMCID: PMC3888795.
  • Cheung CM, Chee SP. Posterior scleritis in children: clinical features and treatment. Ophthalmology 2012 Jan;119(1):59–65. doi:10.1016/j.ophtha.2011.09.030. Epub Dec 3, 2011. PMID: 22137553.
  • Wald KJ, Spaide R, Patalano VJ, et al. Posterior scleritis in children. Am J Ophthalmol. 1992 Mar 15;113(3):281–286. doi:10.1016/s0002-9394(14)71579-x. PMID: 1543220.
  • Woon WH, Stanford MR, Graham EM. Severe idiopathic posterior scleritis in children. Eye (Lond). 1995;9(Pt 5):570–574. doi:10.1038/eye.1995.141. PMID: 8543074.
  • Waduthantri S, MS (Ophth), Chee SP, FRCO phth. Pediatric uveitis and scleritis in a multi-ethnic Asian population. Ocul Immunol Inflamm. 2020 Jul 9;1–8. doi:10.1080/09273948.2020.1766083. Epub ahead of print. PMID: 32643984.
  • Watson PG, Young RD. Scleral structure, organisation and disease. A review. Exp Eye Res. 2004 Mar;78(3):609–623. doi:10.1016/s0014-4835(03)00212-4. PMID: 15106941.
  • Watson PG, Hayreh SS. Scleritis and episcleritis. Br J Ophthalmol. 1976 Mar;60(3):163–191. doi:10.1136/bjo.60.3.163. PMID: 1268179; PMCID: PMC1042706.
  • Wieringa WG, Wieringa JE, Ten Dam-van Loon NH, et al. Visual outcome, treatment results, and prognostic factors in patients with scleritis. Ophthalmology 2013 Feb;120(2):379–386. doi:10.1016/j.ophtha.2012.08.005. Epub Nov 20, 2012. Epub Nov 20, 2012.
  • McCluskey PJ, Watson PG, Lightman S, et al. Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients. Ophthalmology. 1999 Dec;106(12): 2380–2386. doi:10.1016/S0161-6420(99)90543-2. PMID: 10599675.
  • Bang GM, Brodsky MC. Pediatric posterior scleritis. Ophthalmology 2012 Jul; 119(7):1505–1505.e1. doi:10.1016/j.ophtha.2012.03.008. author reply 1505. PMID: 22749104.
  • Dave V, Mathai A. Posterior scleritis in a 9-year-old boy: a case report. Retin Cases Brief Rep. 2012 Winter;6(1):30–32. doi:10.1097/ICB.0b013e3181fe92e5. PMID: 25390705.
  • Erdol H, Kola M, Turk A. Optical coherence tomography findings in a child with posterior scleritis. Eur J Ophthalmol. 2008 Nov-Dec;18(6):1007–1010. doi:10.1177/112067210801800625. PMID: 18988177.
  • Farooq O, Buccilli A, Varma C, et al. Posterior scleritis: a rare pediatric disorder. Clin Pediatr (Phila). 2009 Oct;48(8):869–872. doi:10.1177/0009922809337535. Epub May 29, 2009. PMID: 19483139.
  • Inan S, Ertan E, Inan UU. Multimodal imaging in a child with severe posterior scleritis. Rom J Ophthalmol. 2019 Oct-Dec;63(4):397–402. doi:10.22336/rjo.2019.64. PMID: 31915742; PMCID: PMC6943284.
  • Jensen JE, Fledelius HC, Prause JU, et al. An unusual ophthalmic tumour in a 5-year-old boy. Acta Ophthalmol Suppl. 1992;204:110–112. doi:10.1111/j.1755-3768.1992.tb04941.x. PMID: 1332385.
  • Kellar JZ, Taylor BT. Posterior scleritis with inflammatory retinal detachment. West J Emerg Med. 2015 Dec; 16(7):1175–1176. doi:10.5811/westjem.2015.8.28349. Epub Dec 14, 2015. PMID: 26759674; PMCID: PMC4703173.
  • Kumawat D, Chawla R, Hasan N. Retinochoroidal fold with severe discedema in a case of posterior scleritis. Indian J Ophthalmol. 2020 Apr;68(4):647–649. doi:10.4103/ijo.IJO_1013_19. PMID: 32174593; PMCID: PMC7210866.
  • Mallick J, Pujahari S, Maharana PK. Posterior scleritis presenting as conjunctivitis in a child. BMJ Case Rep. 2016 Dec 9;2016:bcr2016217968. doi:10.1136/bcr-2016-217968. PMID: 27941114; PMCID: PMC5174910.
  • Shenoy R, Suryawanshi M, Isaac R, et al. Posterior scleritis in pediatric age group: a case report and review of literature. Oman J Ophthalmol. 2016 Jan–Apr;9(1): 59–62. doi:10.4103/0974-620X.176121. PMID: 27013832; PMCID: PMC4785712.
  • Weiss K, Rieger R, Keitzer R, et al. Successful infliximab treatment of posterior scleritis in a 13-year-old child refractory to other immunosuppressive therapy. Graefes Arch Clin Exp Ophthalmol. 2007 Nov;245(11):1735–1737. doi:10.1007/s00417-007-0634-1. Epub Aug 3, 2007.
  • van der Maesen K, D’Haens EJ, van Rijn LJ, et al. Posterior scleritis in a 7-month-old infant. J Pediatr Ophthalmol Strabismus. 2007 Nov–Dec;44(6):377–378. doi:10.3928/01913913-20071101-06. PMID: 18062497.
  • Gungor IU, Ariturk N, Beden U, et al. Necrotizing scleritis due to varicella zoster infection: a case report. Ocul Immunol Inflamm. 2006 Oct;14(5):317–319. doi:10.1080/09273940600899890. PMID: 17056468.
  • Kearney FM, Blaikie AJ, Gole GA. Anterior necrotizing scleritis after strabismus surgery in a child. J AAPOS 2007 Apr; 11(2):197–198. doi:10.1016/j.jaapos.2006.09.002. Epub Nov 9, 2006. PMID: 17416330.
  • Rajamani M, Nagasubramanian V, Ayyavoo A, et al. Surgically induced necrotizing scleritis following strabismus surgery treated successfully with topical N-acetylcysteine in a child with congenital fibrosis of extraocular muscles and Varadi Papp syndrome. Strabismus. 2017 Mar;25(1):39–42. doi:10.1080/09273972.2016.1277768. Epub Jan 31, 2017. PMID: 28140732.
  • Venkatesh P, Garg SP, Kumaran E, Tewari HK. Congenital porphyria with necrotizing scleritis in a 9-year-old child. Clin Exp Ophthalmol. 2000 Aug;28(4):314–318. doi:10.1046/j.1442-9071.2000.00330.x. PMID: 11021563.
  • Pujari A, Chaniyara MH, Sharma P, Sharma N. Necrotizing scleritis following uncomplicated strabismus surgery. Indian J Ophthalmol. 2020;68(11):2555–2557. doi:10.4103/ijo.IJO_1839_19.
  • Khurram Butt D, Khan MI, Fathalla BM, Ali SA, Kozak I. Atypical noninfectious surgically induced necrotizing scleritis in a child [published online ahead of print, 2021 Feb 5]. Ocul Immunol Inflamm. 2021;1–3. doi:10.1080/09273948.2020.1836235.
  • Guerrero-Wooley RL, Peacock JE Jr. Infectious scleritis: what the ID Clinician should know. Open Forum Infect Dis. 2018 Jun 11;5(6):ofy140. doi:10.1093/ofid/ofy140. PMID: 29977974; PMCID: PMC6016671.
  • Naseri A, Good WV, Cunningham ET Jr. Herpes zoster virus sclerokeratitis and anterior uveitis in a child following varicella vaccination. Am J Ophthalmol. 2003 Mar;135(3):415–417. doi:10.1016/s0002-9394(02)01957-8. PMID: 12614776.
  • Walton RC, Reed KL. Herpes zoster ophthalmicus following bone marrow transplantation in children. Bone Marrow Transplant. 1999 Jun;23(12):1317–1320. doi:10.1038/sj.bmt.1701796. PMID: 10414922.
  • Bathula BP, Pappu S, Epari SR, et al. Tubercular nodular episcleritis. Indian J Chest Dis Allied Sci. 2012 Apr–Jun;54(2):135–136. PMID: 22973786.
  • Sharma R, Marasini S, Nepal BP. Tubercular scleritis. Kathmandu Univ Med J (KUMJ). 2010 Jul–Sep;8(31):352–356. doi:10.3126/kumj.v8i3.6228. PMID: 22610744.
  • Arora T, Sharma N, Shashni A, et al. Peripheral ulcerative keratitis associated with chronic malabsorption syndrome and miliary tuberculosis in a child. Oman J Ophthalmol. 2015 Sep–Dec;8(3):205–207. doi:10.4103/0974-620X.169888. PMID: 26903734; PMCID: PMC4738673.
  • Paul L, Agarwal M, Singh S, et al. Tuberculous scleritis in a young Asian Indian girl-a case presentation and literature review. J Ophthalmic Inflamm Infect. 2019 Dec 23;9(1):22. doi:10.1186/s12348-019-0192-9. PMID: 31872314; PMCID: PMC6928185.
  • Hilkert SM, Koreishi AF, Pyatetsky D. Poststreptococcal syndrome presenting as posterior scleritis in a child. J AAPOS 2017 Apr;21(2):163–165. doi:10.1016/j.jaapos.2016.09.019. Epub Dec 19, 2016. PMID: 28007653.
  • Berkenstock MK, Carey AR. Health system wide “big data” analysis of rheumatologic conditions and scleritis. BMC Ophthalmol. 2021;21(1):14. doi:10.1186/s12886-020-01769-3.
  • Ramanathan A, and Gaur A. An atypical presentation of posterior scleritis. Int J Ophthalmolo Vis Sci. 2009;8(2).
  • Sacks RD, Stock EL, Crawford SE, et al. Scleritis and Wegener’s granulomatosis in children. Am J Ophthalmol. 1991 Apr 15;111(4):430–433. doi:10.1016/s0002-9394(14)72376-1. PMID: 2012144.
  • Levi M, Kodsi SR, Rubin SE, et al. Ocular involvement as the initial manifestation of Wegener’s granulomatosis in children. J AAPOS. 2008 Feb;12(1):94–96. doi:10.1016/j.jaapos.2007.09.006. Epub Dec 21, 2007. PMID: 18083587.
  • Fernandes SR, Singsen BH, Hoffman GS. Sarcoidosis and systemic vasculitis. Semin Arthritis Rheum. 2000 Aug;30(1):33–46. doi:10.1053/sarh.2000.8364. PMID: 10966211.
  • Uddin JM, Rennie CA, Moore AT. Bilateral non-specific orbital inflammation (orbital “pseudotumour”), posterior scleritis, and anterior uveitis associated with hypothyroidism in a child. Br J Ophthalmol. 2002 Aug;86(8):936. doi:10.1136/bjo.86.8.936. PMID: 12140225; PMCID: PMC1771216.
  • Mansour AM, Khatib L, Mansour HA. Posterior scleritis in familial Mediterranean fever. Case Rep Ophthalmol. 2019 Apr 18;10(1):134–139. doi:10.1159/000499600. PMID: 32231554; PMCID: PMC7098358.
  • Nair N, Abraham S, Ganesh SK. Recurrent posterior scleritis with secondary choroidal osteoma in a child. Indian J Ophthalmol. 2020;68(11):2509–2511. doi:10.4103/ijo.IJO_521_20.
  • Doshi RR, Harocopos GJ, Schwab IR, Cunningham ET Jr. The spectrum of postoperative scleral necrosis. Surv Ophthalmol. 2013;58(6):620–633. doi:10.1016/j.survophthal.2012.11.00265.
  • Contreras-Verduzco FA, Espinosa-Padilla SE, Orozco-Covarrubias L, et al. Pulmonary nodules and nodular scleritis in a teenager with superficial granulomatous pyoderma gangrenosum. Pediatr Dermatol. 2018 Jan;35(1):e35–e38. doi:10.1111/pde.13352. Epub Dec 15, 2017. PMID: 29243307.
  • Karim F, de Hoog J, Paridaens D, et al. IgG4-related disease as an emerging cause of scleritis. Acta Ophthalmol. 2017 Dec;95(8):e795–e796. doi:10.1111/aos.13376. Epub Feb 22, 2017. PMID: 28229544.
  • Braithwaite T, Adderley NJ, Subramanian A, et al. Epidemiology of scleritis in the United Kingdom from 1997 to 2018: population-based analysis of 11 million patients and association between scleritis and infectious and immune-mediated inflammatory disease. Arthritis Rheumatol. 2021;73(7):1267–1276. doi:10.1002/art.417091.
  • Shoughy SS, Jaroudi MO, Tabbara KF. Clinical manifestations and outcome of tuberculous sclerokeratitis. Br J Ophthalmol 2016 Sep;100(9):1301–1303. doi:10.1136/bjophthalmol-2015-307599. Epub Dec 23, 2015. PMID: 26701691.
  • Ramirez-Ortiz MA, Vasquez-Resendis A. Isolated bilateral posterior scleritis after eye trauma. J AAPOS. 2007 Jun;11(3):284–285. doi:10.1016/j.jaapos.2006.09.019. Epub Jan 25, 2007. PMID: 17257871.
  • Sainz de La Maza M. Scleritis immunopathology and therapy. Dev Ophthalmol. 1999;30:84–90. doi:10.1159/000060738. PMID: 10627918.
  • Riono WP, Hidayat AA, Rao NA. Scleritis: a clinicopathologic study of 55 cases. Ophthalmology. 1999 Jul;106(7):1328–1333. doi:10.1016/S0161-6420(99)00719-8. PMID: 10406616.
  • Hankins M, Margo CE. Histopathological evaluation of scleritis. J Clin Pathol. 2019 May;72(5):386–390. doi:10.1136/jclinpath-2018-205360. Epub Feb 5, 2019. PMID: 30723093.
  • Fong LP, Sainz de La Maza M, Rice BA, et al. Immunopathology of scleritis. Ophthalmology. 1991 Apr;98(4):472–479. doi:10.1016/s0161-6420(91)32280-2. PMID: 1828871.
  • Wakefield D, Di Girolamo N, Thurau S, et al. Scleritis: immunopathogenesis and molecular basis for therapy. Prog Retin Eye Res. 2013 Jul;35:44–62. doi:10.1016/j.preteyeres.2013.02.004. Epub Feb 26, 2013. PMID: 23454614.
  • Di Girolamo N, Lloyd A, McCluskey P, et al. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts. Am J Pathol. 1997 Feb;150(2):653–666. PMID: 9033278; PMCID: PMC1858288.
  • Fabiani C, Sota J, Sainz-de-la-maza M, et al. Effectiveness of TNF-α blockade in the treatment of refractory non-infectious scleritis: a multicentre study. Clin Exp Rheumatol. 2020;38(6):1138–1144.
  • Fabiani C, Sota J, Tosi GM, et al. The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases. Clin Rheumatol. 2017 Oct;36(10):2307–2318. doi:10.1007/s10067-016-3527-z. Epub Dec 28, 2016. PMID: 28032234.
  • Nieuwenhuizen J, Watson PG, Emmanouilidis-van der Spek K, et al. The value of combining anterior segment fluorescein angiography with indocyanine green angiography in scleral inflammation. Ophthalmology. Aug 2003;110(8):1653–1666. doi:10.1016/S0161-6420(03)00487-1. Erratum in: Ophthalmology. 2004 Feb;111(2):331. PMID: 12917189.
  • Li L, Dalvin LA, Shields CL. Atypical fundus mass in a child. JAMA Ophthalmol. 2019 Mar 1;137(3):322–323. doi:10.1001/jamaophthalmol.2018.5443. PMID: 30629102.
  • Oray M, Meese H, Foster CS. Diagnosis and management of non-infectious immune-mediated scleritis: current status and future prospects. Expert Rev Clin Immunol. 2016 Aug;12(8):827–837. doi:10.1586/1744666X.2016.1171713. Epub Apr 8, 2016. PMID: 27055583.
  • Gupta N, Ganger A, Bhartiya S, et al. In vivo confocal microscopic characteristics of crystalline keratopathy in patients with sclerokeratitis. Ocul Immunol Inflamm. 2018;26(5):700–705. doi:10.1080/09273948.2017.1281422. Epub Feb 22, 2017. PMID: 28282739.
  • Sohn EH, Wang R, Read R, et al. Long-term, multicenter evaluation of subconjunctival injection of triamcinolone for non-necrotizing, noninfectious anterior scleritis. Ophthalmology. 2011 Oct;118(10):1932–1937. doi:10.1016/j.ophtha.2011.02.043. Epub Jun 25, 2011. PMID: 21708408; PMCID: PMC3184362.
  • Daniel E, Thorne JE, Newcomb CW, et al. Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol. 2010 Mar;149(3):423–32.e1-2. doi:10.1016/j.ajo.2009.09.026. Epub Dec 30, 2009. PMID: 20042178; PMCID: PMC2826576.
  • Gangaputra S, Newcomb CW, Liesegang TL, et al. Systemic immunosuppressive therapy for eye diseases cohort study. Methotrexate for ocular inflammatory diseases. Ophthalmology. 2009 Nov;116(11):2188–98.e1. doi:10.1016/j.ophtha.2009.04.020. Epub Sep 12, 2009. PMID: 19748676; PMCID: PMC3785935.
  • Pasadhika S, Kempen JH, Newcomb CW, et al. Azathioprine for ocular inflammatory diseases. Am J Ophthalmol. 2009 Oct;1484:500–509.e2. doi:10.1016/j.ajo.2009.05.008. Epub Jul 1, 2009. PMID: 19570522; PMCID: PMC2753718.
  • Gangaputra SS, Newcomb CW, Joffe MM, et al. Comparison between methotrexate and mycophenolate mofetil monotherapy for the control of noninfectious ocular inflammatory diseases. Am J Ophthalmol. 2019 Dec;208:68–75. doi:10.1016/j.ajo.2019.07.008. Epub Jul 22, 2019. PMID: 31344346; PMCID: PMC6889035.
  • Galor A, Jabs DA, Leder HA, et al. Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation. Ophthalmology. 2008 Oct;115(10):1826–1832. doi:10.1016/j.ophtha.2008.04.026. Epub Jun 25, 2008. PMID: 18579209.
  • Jabs DA, Rosenbaum JT. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2001 May;131(5):679. doi:10.1016/s0002-9394(01)00830-3. PMID: 11354352.
  • Fabiani C, Sota J, Sainz-de-la-maza M, et al. New potential weapons for refractory scleritis in the era of targeted therapy. Mediators Inflamm. 2020 Jan 17;2020:8294560. doi:10.1155/2020/8294560. PMID: 32410867; PMCID: PMC7201583.
  • Khalili S, Mireskandari K. Infliximab for management of severe refractory posterior scleritis in a 9-year-old boy. Can J Ophthalmol. 2021;56(3):e92–e94. doi:10.1016/j.jcjo.2020.11.013.
  • Cao JH, Oray M, Foster CS. Rituximab in the treatment of refractory noninfectious scleritis. Am J Ophthalmol. 2016 Jun;166:207–208. doi:10.1016/j.ajo.2016.03.037. Epub May 7, 2016. PMID: 27161988.
  • Joshi L, Tanna A, McAdoo SP, et al. Long-term outcomes of rituximab therapy in ocular granulomatosis with polyangiitis: impact on localized and nonlocalized disease. Ophthalmology. 2015 Jun;122(6):1262–1268. doi:10.1016/j.ophtha.2015.01.016. Epub Mar 4, 2015. PMID: 25745876.
  • Suhler EB, Lim LL, Beardsley RM, et al. Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging, randomized, clinical trial. Ophthalmology. 2014 Oct;121(10):1885–1891. doi:10.1016/j.ophtha.2014.04.044. Epub Jun 20, 2014. PMID: 24953794.
  • Ng CC, Sy A, Cunningham ET Jr. Rituximab for non-infectious Uveitis and Scleritis. J Ophthalmic Inflamm Infect. 2021;11(1):23. doi:10.1186/s12348-021-00252-4.
  • Cunningham ET, Adán A, Nguyen QD, et al. Tocilizumab for the treatment of ocular inflammatory disease. Ocul Immunol Inflamm. 2021;29(1):2–5. doi:10.1080/09273948.2020.1859257.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.